Post-lesion Administration of Dexamethasone to Prevent the Development of Neuritis After Radiofrequency Ablation
Status:
Recruiting
Trial end date:
2022-09-01
Target enrollment:
Participant gender:
Summary
Chronic neck and back pain has become one of the leading causes of disability and loss of
productivity. For many patients with facet or sacroiliac joint mediated pain who have
responded to diagnostic nerve blocks, radiofrequency ablation of the nerves innervating the
joints can provide long term relief. Radiofrequency ablation (RFA) is a relatively safe
procedure with minimal risk of adverse events. However, with any procedure involving damage
to the peripheral nervous system, there is risk of post-procedure neuropathic pain. The
investigators will test the hypothesis that dexamethasone injection delivered at the time of
lesion effectively prevents the development of post-ablation neuritis through a
placebo-controlled, double-blind, randomized trial in patients undergoing cervical, thoracic,
lumbar, and sacroiliac joint radiofrequency denervations